Consultations in Molecular Diagnostics Molecular Diagnosis of Metastasizing

[1]  J. Torhorst,et al.  PTEN as a Molecular Marker to Distinguish Metastatic From Primary Synchronous Endometrioid Carcinomas of the Ovary and Uterus , 2003, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[2]  C. Burger,et al.  Clinical importance of molecular determinations in gynecologic patients with multiple tumors , 2003, Cancer.

[3]  J. Eshleman,et al.  Molecular Diagnosis of Oligodendroglioma in Paraffin Sections , 2003, Laboratory Investigation.

[4]  C. Shieff,et al.  Metastasis to and from the central nervous system--the 'relatively protected site'. , 2002, The Lancet. Oncology.

[5]  Rebecca A Betensky,et al.  Histopathological‐Molecular Genetic Correlations in Referral Pathologist‐Diagnosed Low‐Grade “Oligodendroglioma” , 2002, Journal of neuropathology and experimental neurology.

[6]  Robert B. Jenkins,et al.  Losses of Chromosomal Arms 1p and 19q in the Diagnosis of Oligodendroglioma. A Study of Paraffin-Embedded Sections , 2001, Modern Pathology.

[7]  J. Tonn,et al.  Extraneural Metastases of Primary Brain Tumors , 2001, Journal of Neuro-Oncology.

[8]  R A Betensky,et al.  Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  D. Brat,et al.  Extraneural metastatic glioblastoma after interstitial brachytherapy. , 2000, International journal of radiation oncology, biology, physics.

[10]  B. Scheithauer,et al.  Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  J. Rey,et al.  hRAD54 gene and 1p high-resolution deletion-mapping analyses in oligodendrogliomas. , 2000, Cancer genetics and cytogenetics.

[12]  R. McLendon,et al.  Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. , 1999, The American journal of pathology.

[13]  B. Scheithauer,et al.  Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype , 1999, Oncogene.

[14]  D. Louis,et al.  Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. , 1998, Journal of the National Cancer Institute.

[15]  I. Penn,et al.  Peritoneal metastasis of intracranial glioblastoma via a ventriculoperitoneal shunt preventing organ retrieval: case report and review of the literature. , 1998, Clinical transplantation.

[16]  P. Barber,et al.  Parotid gland metastases of two uncommon neoplasms with low metastatic potential. , 1997, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[17]  D K Pearl,et al.  Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas , 1997, Cancer.

[18]  P. Bugert,et al.  Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis. , 1996, The American journal of pathology.

[19]  G. Miserocchi,et al.  Metastatic oligodendroglioma. Case report. , 1996, Journal of neurosurgical sciences.

[20]  R. Sciot,et al.  Diagnosis of primary renal cell carcinoma in a left supraclavicular lymph node by chromosome analysis. , 1996, The Journal of urology.

[21]  T. C. Barnett,et al.  Single-tube protocol for the extraction of DNA or RNA from paraffin-embedded tissues using a starch-based adhesive. , 1996, BioTechniques.

[22]  G. Reifenberger,et al.  Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. , 1994, The American journal of pathology.

[23]  H. Steininger,et al.  [Oligodendroglioma with cervical lymph node metastasis]. , 1993, Der Pathologe.

[24]  B. Scheithauer,et al.  The New WHO Classification of Brain Tumours , 1993, Brain pathology.

[25]  N. Ordóñez,et al.  Pathological evaluation of neoplasms with unknown primary tumor site. , 1993, Seminars in oncology.

[26]  R. Motzer,et al.  Genetic analysis in the diagnosis of neoplasms of unknown primary tumor site. , 1993, Seminars in oncology.

[27]  H. Hoffman,et al.  Extraneural metastases of central nervous system tumors , 1985, Cancer.

[28]  J. Chason,et al.  Surgical Pathology of the Nervous System and Its Coverings , 1983 .

[29]  Olufunmilayo I. Olopade,et al.  The Chromosomes in Human Cancer and Leukemia , 1981 .

[30]  D. Wight,et al.  Metastasizing ependymoma of the cauda equina , 1973, Journal of clinical pathology.

[31]  P. Bailey,et al.  A classification of the tumors of the glioma group on a histogenetic basis with a correlated study of prognosis , 1970 .

[32]  D. J. Mackenzie.  A Classification of the Tumours of the Glioma Group on a Histogenetic Basis With a Correlated Study of Prognosis , 1926 .

[33]  Takaaki Kirino,et al.  Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.